Nutrition, Metabolism & Cardiovascular Diseases
Volume 22, Issue 1 , Pages 58-65 , January 2012

Effects of chronic elevation of atrial natriuretic peptide and free fatty acid levels in the induction of type 2 diabetes mellitus and insulin resistance in patients with mitral valve disease

  • L.D. Monti

      Affiliations

    • Cardiodiabetes and Core Laboratory, Metabolic and Cardiovascular Science Division, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 0226432819; fax: +39 0226433839.
    • ,
  • P.C.G. Lucotti

      Affiliations

    • Internal Medicine Department, Cardio-Metabolic and Clinical Trials Unit, Metabolic and Cardiovascular Science Division, San Raffaele Scientific Institute, 20132 Milan, Italy
    • ,
  • E. Setola

      Affiliations

    • Internal Medicine Department, Cardio-Metabolic and Clinical Trials Unit, Metabolic and Cardiovascular Science Division, San Raffaele Scientific Institute, 20132 Milan, Italy
    • ,
  • A. Rossodivita

      Affiliations

    • Cardio-thoraco-vascular Department, Metabolic and Cardiovascular Science Division, San Raffaele Scientific Institute, 20132 Milan, Italy
    • ,
  • M.G. Pala

      Affiliations

    • Cardio-thoraco-vascular Department, Metabolic and Cardiovascular Science Division, San Raffaele Scientific Institute, 20132 Milan, Italy
    • ,
  • E. Galluccio

      Affiliations

    • Cardiodiabetes and Core Laboratory, Metabolic and Cardiovascular Science Division, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy
    • ,
  • G. LaCanna

      Affiliations

    • Cardio-thoraco-vascular Department, Metabolic and Cardiovascular Science Division, San Raffaele Scientific Institute, 20132 Milan, Italy
    • ,
  • A. Castiglioni

      Affiliations

    • Cardio-thoraco-vascular Department, Metabolic and Cardiovascular Science Division, San Raffaele Scientific Institute, 20132 Milan, Italy
    • ,
  • M. Cannoletta

      Affiliations

    • Cardio-thoraco-vascular Department, Metabolic and Cardiovascular Science Division, San Raffaele Scientific Institute, 20132 Milan, Italy
    • ,
  • C. Meloni

      Affiliations

    • Cardio-thoraco-vascular Department, Metabolic and Cardiovascular Science Division, San Raffaele Scientific Institute, 20132 Milan, Italy
    • ,
  • I. Zavaroni

      Affiliations

    • Internal Medicine and Biomedical Science Department, Parma University, Parma, Italy
    • ,
  • E. Bosi

      Affiliations

    • Cardiodiabetes and Core Laboratory, Metabolic and Cardiovascular Science Division, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy
    • Internal Medicine Department, Cardio-Metabolic and Clinical Trials Unit, Metabolic and Cardiovascular Science Division, San Raffaele Scientific Institute, 20132 Milan, Italy
    • Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Milan, Italy
    • ,
  • O. Alfieri

      Affiliations

    • Cardio-thoraco-vascular Department, Metabolic and Cardiovascular Science Division, San Raffaele Scientific Institute, 20132 Milan, Italy
    • Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Milan, Italy
    • ,
  • P.M. Piatti

      Affiliations

    • Cardiodiabetes and Core Laboratory, Metabolic and Cardiovascular Science Division, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy
    • Vita-Salute San Raffaele University, Scientific Institute San Raffaele, Milan, Italy

Received 30 October 2009 ,Revised 31 March 2010 ,Accepted 9 April 2010.

References 

  1. Dessì-Fulgheri P, Sarzani R, Rappelli A. Role of the natriuretic peptide system in lipogenesis/lipolysis. Nutr Metab Cardiovasc Dis. 2003;13:244–249
  2. Sengenes C, Bouloumie A, Hauner H, Berlan M, Busse R, Lafontan M, et al. Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J Biol Chem. 2003;278:48617–48626
  3. Lafontan M, Moro C, Berlan M, Crampes F, Sengenes C, Galitzky C. Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol Metab. 2008;19:130–137
  4. Birkenfeld AL, Boschmann M, Moro C, Adams F, Heusser K, Tank J, et al. β-Adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation. J Clin Endocrinol Metab. 2006;91:5069–5075
  5. Moro C, Galitzky J, Sengenes C, Crampes F, Lafontan M, Berlan M. Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells. J Pharmacol Exp Ther. 2004;308:984–992
  6. Sengenès C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J. Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J. 2000;14:1345–1351
  7. Lafontan M, Moro C, Sengenes C, Galitzky J, Crampes F, Berlan M. An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans. Arterioscler Thromb Vasc Biol. 2005;25:2032–2042
  8. D’Souza SP, Davis M, Baxter GF. Autocrine and paracrine actions of natriuretic peptides in the heart. Pharmacol Ther. 2004;101:113–129
  9. Birkenfeld AL, Budziarek P, Boschmann M, Moro C, Adams F, Franke G, et al. Atrial natriuretic peptide induces postprandial lipid oxidation in humans. Diabetes. 2008;57:3199–3204
  10. Wamback G, Hannekum A, Schmidt S. Increased concentrations of atrial natriuretic peptide (ANP) in plasma and in the atrial tissue of patients with aortal and mitral dysfunction compared with patients with coronary heart disease. Z Kardiologie. 1987;76:76–80
  11. Ray SG. Natriuretic peptides in mitral valve disease. Heart. 2006;92:1194–1197
  12. Birkenfeld AL, Boschmann M, Moro C, Adams F, Heusser K, Franke G, et al. Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. J Clin Endocrinol Metab. 2005;90:3622–3628
  13. Galitzky J, Sengenes C, Thalamas C, Marques MA, Senard JM, Lafontan M, et al. The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men. J Lipid Res. 2001;42:536–544
  14. Bays H, Mandarino L, DeFronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab. 2004;89:463–478
  15. Hassan A, Quan H, Newman A, Ghali WA, Hirsch GM. Canadian cardiovascular outcomes research team. Outcomes after aortic and mitral valve replacement surgery in Canada: 1994/95 to 1999/2000. Can J Cardiol. 2004;20:155–163
  16. Taylor NE, O’Brien S, Edwards FH, Peterson ED, Bridges CR. Relationship between race and mortality and morbidity after valve replacement surgery. Circulation. 2005;111:1305–1312
  17. Chen Y, Wright S, Westfall R. Reversed gender distribution of diabetes in Northern Canada. Public Health. 2009;123:782–786
  18. Miyashita K, Itoh H, Tsujimoto H, Tamura N, Fukunaga Y, Sone M, et al. Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes. 2009;58:2880–2892
  19. Nakatsuji H, Maeda N, Hibuse T, Hiuge A, Hirata A, Kuroda Y, et al. Reciprocal regulation of natriuretic peptide receptors by insulin in adipose cells. Biochem. Biophys Res Commun. 2010;1:100–105
  20. Nishikimi T, Iemura-Inaba C, Akimoto K, Ishikawa K, Koshikawa S, Matsuoka H. Stimulatory and inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/Gi pathways in rat cultured adipocytes. Regul Pept. 2009;153:56–63
  21. Ogawa T, Linz W, Stevenson M, Bruneau BG, Kuroski de Bold ML, Chen JH, et al. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. Circulation. 1996;93:2059–2067
  22. Wang TJ, Larson MG, Levy D, Larson MG, Levy D, Vasan RS, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109:594–600
  23. Wang TJ, Larson MG, Keyes MJ, Levy D, Benjamin EJ, Vasan RS. Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation. 2007;115:1345–1353
  24. Dessi-Fulgheri P, Sarzani R, Tamburrini P, Moraca A, Espinosa E, Cola G, et al. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens. 1997;15:1695–1699
  25. Oral H, Sivasubramanian N, Dyke DB, Mehta RH, Grossman PM, Briesmiester K, et al. Myocardial proinflammatory cytokine expression and left ventricular remodeling in patients with chronic mitral regurgitation. Circulation. 2003;107:831–837
  26. Cheng KH, Chu CS, Lee KT, Lin TH, Hsieh CC, Chiu CC, et al. Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes. 2008;32:268–274
  27. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm ER. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291:1730–1737
  28. Rizza S, Clementi F, Porzio O, Cardellini M, Savo A, Serino M, et al. Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD. Nutr Metab Cardiovasc Dis. 2009;19:54–60

PII: S0939-4753(10)00103-1

doi: 10.1016/j.numecd.2010.04.005

Nutrition, Metabolism & Cardiovascular Diseases
Volume 22, Issue 1 , Pages 58-65 , January 2012

Article Tools

* Image Usage & Resolution